Mease, Philip J <br/><br/>
Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data.  [electronic resource] 

 -  The Annals of pharmacotherapy  Feb 2011 
 - 179-88 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1542-6270 
<br/><br/><label>Standard No.: </label>10.1345/aph.1P391  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Uptake Inhibitors--adverse effects<br/>Adult<br/>Amitriptyline--adverse effects<br/>Antidepressive Agents--adverse effects<br/>Cardiovascular Diseases--chemically induced<br/>Cyclopropanes--adverse effects<br/>Female<br/>Heart Failure--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Milnacipran<br/>Myocardial Infarction--chemically induced<br/>Retrospective Studies<br/>Risk<br/>Selective Serotonin Reuptake Inhibitors--adverse effects<br/>Stroke--chemically induced<br/>United States<br/>Venlafaxine Hydrochloride--therapeutic use